KORU Medical Systems, Inc. announced a 23% increase in Q4 2025 revenues to $10.9 million, with a full-year revenue growth of 22% to $41.1 million. The company achieved a positive adjusted EBITDA of $0.6 million, reflecting a 124% improvement. Guidance for 2026 indicates continued growth.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.